It works by stimulating insulin secretion after a meal, reducing glucagon secretion, delaying gastric emptying, causing a reduction in hunger and food intake, slowing the release of food from the stomach, and increasing feelings of fullness after eating(2 Trusted Source Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide-1 Receptor Agonists Go to source)
Nonetheless, there was no change reported regarding the SRS total raw scores and hyperactivity symptoms
Kilburn, Donald P
Article contents Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action Published online by Cambridge University Press: 18 August 2023 Abstract Keywords Information Type Perspective Information Journal of Clinical and Translational Science , Volume 7 , Issue 1 , 2023 , e184 Creative Commons This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ( which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited
Potential renal benefits: some evidence suggests reduction in albuminuria and slowing of kidney disease progression
